Umbilical cord blood-derived mesenchymal stem cells in treating a critically ill COVID-19 patient

Abstract

Our current findings suggested that UCB-MSCs therapy may show some positive effect in treating critical COVID-19 to some extent, for its delaying deterioration of the disease and efficacy in respiratory and renal function, though limited.